Corona Remedies Ltd
Company Profile
Business description
Corona Remedies Ltd is mainly engaged in the business of manufacturing, trading and marketing of Pharmaceutical products. It is engaged in developing, manufacturing and marketing products in women's healthcare, cardio-diabetes, pain management, urology and other segments, such as Vitamin Minerals and Nutrients(VMN), gastrointestinal and respiratory therapies. The company's brands are B-29, myoril, Tricium, Cortel, and Obimet. The Company has only one reportable business segment i.e. Pharmaceuticals. The company has presence in India as well as Outside India. The company generates majority of revenue from India.
Contact
S. G. Highway, CORONA House
C - Mondeal Business Park, Near Gurudwara
Thaltej
AhmedabadGJ380 059
INDT: +91 7940233000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 March 2027
Employees
5,686
Stocks News & Analysis
stocks
Margins have bottomed for ASX listed consumer goods company
stocks
SpaceX rally continues, expanding sky-high valuations
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,031.20 | 9.40 | 0.10% |
| CAC 40 | 8,398.48 | 22.66 | -0.27% |
| DAX 40 | 25,105.44 | 119.62 | 0.48% |
| Dow JONES (US) | 51,711.30 | 146.60 | 0.28% |
| FTSE 100 | 10,425.40 | 62.13 | 0.60% |
| HKSE | 23,768.52 | 156.29 | -0.65% |
| NASDAQ | 26,242.59 | 275.34 | -1.04% |
| Nikkei 225 | 72,353.96 | 1,103.90 | 1.55% |
| NZX 50 Index | 13,446.05 | 49.58 | -0.37% |
| S&P 500 | 7,477.67 | 22.91 | -0.31% |
| S&P/ASX 200 | 8,816.10 | 14.20 | 0.16% |
| SSE Composite Index | 4,163.10 | 72.62 | 1.78% |